...
首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >Fast and sensitive chemiluminescence assay of aminophylline in human serum using luminol-diperiodatoargentate(III) system catalyzed by coated iron nanoparticles
【24h】

Fast and sensitive chemiluminescence assay of aminophylline in human serum using luminol-diperiodatoargentate(III) system catalyzed by coated iron nanoparticles

机译:包覆铁纳米粒子催化鲁米诺-二过碘代Argentate(III)体系快速灵敏地测定人血清中氨茶碱的化学发光

获取原文
获取原文并翻译 | 示例
           

摘要

The CL intensity of luminol-diperiodatoargentate(III) (DPA) system is strongly enhanced by addition of iron nanoparticles (FeNPs) covered with C12E4. On injection of aminophylline into luminol-DPA-FeNPs system, the CL intensity is significantly increased. On this basis, a sensitive CL assay was developed for determination of AmP in human serum. FeNPs could catalyze the oxidation rate of luminol in the present of oxygen. Also, the CL intensity of luminol-DPA-FeNPs system is significantly increased in the presence of aminophylline (AmP). Based on this ruling, a sensitive CL assay was developed for determination of AmP in human serum. The influences of analytical variables on the CL signal were studied and optimized. Under the optimum conditions in the present of FeNPs, the CL intensity is linearly increased with AmP concentration in the range of 1.0 × 10 ~(-8)-2.0 × 10 ~(-6) mol L ~(-1). The detection limit was 9.8 × 10 ~(-9) mol L ~(-1) AmP and the relative standard deviation for ten parallel measurements of 8.0 × 10 ~(-7) mol L ~(-1) AmP was also 4.8%. The proposed system was successfully applied to determine AmP in human serum samples.
机译:通过添加被C12E4覆盖的铁纳米颗粒(FeNPs),鲁米诺-二高碘酸盐(III)(DPA)系统的CL强度得到了极大的增强。将氨茶碱注射入鲁米诺-DPA-FeNPs系统后,CL强度显着增加。在此基础上,开发了一种灵敏的CL测定法,用于测定人血清中的AmP。 FeNPs可在氧气存在下催化鲁米诺的氧化速率。此外,在氨茶碱(AmP)存在的情况下,鲁米诺-DPA-FeNPs系统的CL强度显着增加。基于此裁定,开发了一种灵敏的CL测定法,用于测定人血清中的AmP。研究和优化了分析变量对CL信号的影响。在目前存在的FeNPs的最佳条件下,CL强度随AmP浓度在1.0×10〜(-8)-2.0×10〜(-6)mol L〜(-1)范围内线性增加。检测限为9.8×10〜(-9)mol L〜(-1)AmP,十次平行测量的8.0×10〜(-7)mol L〜(-1)AmP的相对标准偏差也为4.8%。 。所提出的系统已成功应用于测定人血清样品中的AmP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号